G. Piringer

Novel approaches in adjuvant colorectal cancer therapy: the emerging role of exercise, aspirin, and immunotherapy

Adjuvant treatment of colorectal cancer (CRC) has traditionally been based on fluoropyrimidine- and oxaliplatin-based chemotherapy regimens, which remain the cornerstone of care for patients with resected stage III and selected high-risk stage II disease. However, despite substantial improvements in disease-free (DFS...